Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,908 | -19,423 | -13,593 | -9,275 | -4,834 |
| Depreciation Amortization | 15 | 55 | 39 | 26 | 13 |
| Income taxes - deferred | N/A | -94 | N/A | N/A | N/A |
| Other Working Capital | -441 | 1,465 | 307 | 995 | 653 |
| Other Operating Activity | 838 | 6,048 | 3,671 | 2,207 | 1,325 |
| Operating Cash Flow | $-2,497 | $-11,949 | $-9,576 | $-6,047 | $-2,843 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -65 | -65 | -65 | -31 |
| Net Acquisitions | N/A | 31 | 31 | 31 | 31 |
| Investing Cash Flow | $N/A | $-34 | $-34 | $-34 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 11,750 | N/A | N/A | N/A |
| Common Stock Issued | 9,124 | 1,895 | 12,390 | 6,890 | 4,081 |
| Financing Cash Flow | $9,124 | $13,645 | $12,390 | $6,890 | $4,081 |
| Beginning Cash Position | 6,062 | 4,401 | 4,401 | 4,401 | 4,401 |
| End Cash Position | 12,689 | 6,062 | 7,180 | 5,210 | 5,638 |
| Net Cash Flow | $6,627 | $1,661 | $2,779 | $809 | $1,237 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,497 | -11,949 | -9,576 | -6,047 | -2,843 |
| Capital Expenditure | N/A | -65 | -65 | -65 | -31 |
| Free Cash Flow | -2,497 | -12,014 | -9,641 | -6,111 | -2,874 |